Henan Lingrui Pharmaceutical Co (SHSE:600285) Total Liabilities: ¥2,280 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
93 GF Score
Price ¥22.70
GF Value ¥24.40
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Henan Lingrui Pharmaceutical Co Total Liabilities?

Henan Lingrui Pharmaceutical Co SHSE:600285 +0.18% 93 Total Liabilities is ¥2,280 Mil as of Mar. 2026. GuruFocus rates SHSE:600285 with a GF Score™ of 93/100 and a GF Value™ of ¥24.40 (Fairly Valued). The stock has 2 warning signs investors should review.

Henan Lingrui Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2026 was ¥2,280 Mil.

Henan Lingrui Pharmaceutical Co's quarterly Total Liabilities declined from Sep. 2025 (¥2,472.40 Mil) to Dec. 2025 (¥2,199.59 Mil) but then increased from Dec. 2025 (¥2,199.59 Mil) to Mar. 2026 (¥2,280.36 Mil).

Henan Lingrui Pharmaceutical Co's annual Total Liabilities declined from Dec. 2023 (¥1,973.22 Mil) to Dec. 2024 (¥1,936.55 Mil) but then increased from Dec. 2024 (¥1,936.55 Mil) to Dec. 2025 (¥2,199.59 Mil).

Henan Lingrui Pharmaceutical Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Henan Lingrui Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Lingrui Pharmaceutical Co Total Liabilities Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,506.51 1,786.26 1,973.22 1,936.55 2,199.59

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,067.03 2,471.92 2,472.40 2,199.59 2,280.36
SHSE:600285
93GF Score
Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henan Lingrui Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Henan Lingrui Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2115.579+(4.272+79.742
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2,200

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=5635.507-3435.914
=2,200

Henan Lingrui Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2191.225+(4.56+84.574
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2,280

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=5965.685-3685.325
=2,280

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ¥2,280 Mil mean?
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a Total Liabilities of ¥2,280 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Henan Lingrui Pharmaceutical Co and its competitors.
Is Henan Lingrui Pharmaceutical Co's Total Liabilities too high?
Henan Lingrui Pharmaceutical Co's current Total Liabilities is ¥2,280 Mil. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's Total Liabilities compare to ZTS and UTHR?
Henan Lingrui Pharmaceutical Co's Total Liabilities of ¥2,280 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Henan Lingrui Pharmaceutical Co and its competitors. Henan Lingrui Pharmaceutical Co's current Total Liabilities is ¥2,280 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.40, compared to a current price of ¥22.70 — trading 7% below its estimated fair value. The current Total Liabilities is ¥2,280 Mil. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current Total Liabilities is ¥2,280 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?

Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥22.70 is trading 7% below its estimated GF Value™ of ¥24.40. GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600285:

  • Total Liabilities: ¥2,280 Mil
  • GF Value™: ¥24.40 vs. price of ¥22.70 (7% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Henan Lingrui Pharmaceutical Co Business Description

Address No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
93GF Score

Get the complete analysis for SHSE:600285

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.70
Price
¥24.40
GF Value